Sentences with phrase «dividend increases at»

The company traditionally announces dividend increases at the beginning of March, with the stock going ex-dividend at the beginning of April.

The company announces annual dividend increases at the end of September, with the increased dividend going to shareholders of record in mid-October.

The company announces dividend increases at the end of May or beginning of June, with the stock going ex-dividend at the beginning of June.

The company traditionally announces dividend increases at the end of October, with the stock going ex-dividend in December.

The company announces annual dividend increases at the end of January, with the stock going ex-dividend at the beginning of March.

The company announces annual dividend increases at the end of January, with the stock going ex-dividend in the first half of February.

The company traditionally announces annual dividend increases at the beginning of May, with the stock going ex-dividend in the middle of May.

The company usually announces annual dividend increases at the beginning of May with the stock going ex-dividend at the beginning of June.

For the last decade, the company has announced dividend increases at the end of January and the stock has gone ex-dividend for the increase at the beginning of March.

I'll touch on dividend increases at the end of this post.

It has increased its dividend for the past 21 consecutive years and the last decade has seen the dividend increase at an annual rate of 13.8 %.

Unfortunately, the company announced a disappointing 3 % dividend increase at the end of the month.

Couple that with a likely dividend increase at the end of the month, and I felt good about buying these shares at this particular moment.

In this scenario the warrant strike price is reduced by the dividends paid (I assumed dividends increased at a linear rate, not all in the last year).

Not exact matches

One way small investors can imitate that approach: Buying the ProShares S&P 500 Dividend Aristocrats ETF (NOBL), which owns shares in companies that have increased dividends for at least 25 consecutive years.

While the dividend gross - up for non-eligible disbursement has been reduced — from 25 % to18 % — the amount of tax on these disbursements has increased by approximately 1.6 %, explained Don Carson, a chartered accountant representing the CICA, and a tax partner at Markham, Ont. - based MNP accounting firm.

While some banks, such as Wells Fargo, are paying more per share than they were before the recession, others, like Citigroup, haven't increased dividends at all.

«We believe the bogey for investors is a 15 percent increase to Apple's total reported capital return number (shares repurchase plus past dividends), which would imply a $ 150 billion headline number, up from $ 130 billion announced last year,» said Gene Munster, an analyst at Piper Jaffray, in a recent note.

At the same time, the company has increased its dividend by 33 % over the past five years, yet its payout ratio is a paltry 9 %.

It also announced plans to increase its dividend by 21 percent and to repurchase at least $ 5 billion in stock in 2018.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

The deceptive company then borrows money to pay for the increased dividend while personally selling shares at the inflated price.

Comcast also announces plans to increase its dividend by 21 percent and to repurchase at least $ 5 billion in stock in 2018.

The first four months of the year saw 169 companies in the S&P 500 index increase their dividends while no companies cut their shareholder payouts, «an event not seen since at least 2003,» Silverblatt says.

Companies in the S&P 500 are on track to give investors more than $ 1 trillion in stock buybacks and dividend increases this year, according to Howard Silverblatt, a senior analyst at S&P Dow...

-LSB-...] The Dividend Achievers Index refers to all public companies that have successfully increased their dividend payments for at least ten consecutivDividend Achievers Index refers to all public companies that have successfully increased their dividend payments for at least ten consecutivdividend payments for at least ten consecutive years.

The Dividend Achievers Index refers to all public companies that have successfully increased their dividend payments for at least ten consecutivDividend Achievers Index refers to all public companies that have successfully increased their dividend payments for at least ten consecutivdividend payments for at least ten consecutive years.

The Dividend Achievers Index refers to all public companies that have successfully increase their dividend payments for at least ten consecutivDividend Achievers Index refers to all public companies that have successfully increase their dividend payments for at least ten consecutivdividend payments for at least ten consecutive years.

I'm increasing my income level at a much faster pace organically without even making contributions due to dividend increases and a constantly growing portfolio.

Instead, it looks for TSX - listed companies that have at least $ 300 mln in market cap and have paid and increased their dividends over each of the last five years.

In my experience, a dividend growth portfolio strategy seems to be performing better as an investment than owning a home, in my honest opinion, I would rather rent in a great area than own a home in that area, jeez if I were able to get a lease agreement for 10 years indexed at inflation or at 2.5 % increase annually I would take it and take my down payment and invest it in my portfolio, and continue to contribute the max in my 401K, HSA, and Roth IRA, while enjoying living in a low tax bracket because of my contributions.

When factoring in my dividend reinvestments, dividend increases / decreases, and stock purchases, my forward 12 - month dividends increased to at $ 2,163.95.

But the real emergency affects mainly debtors — mortgage debtors with negative equity, companies loaded down with junk bonds (many of them taken to buy back corporate stock and increase dividend payouts to increase the price at which managers can cash out).

Melcor Developments Ltd (MRD) is in at least its 6th year of dividend increase.

Streaks are re-evaluated at the end of the year so if Shaw increases their dividend sometime in the remainder of 2017 they will still have their streak intact too.

Streaks are re-evaluated at the end of the year so if Accord increases their dividend sometime in the remainder of 2017 they will still have their streak intact too.

Loved seeing that increase from ADM. January was a huge month for dividend increases as I was expecting 3 - 4 and got 8, actually at least 10 if you count the smaller holdings in my secondary accounts.

Royal Bank of Canada (RY on TSX and NYSE) today announced an increase to its quarterly common share dividend of two cents per share, or three percent, to 79 cents per share, payable on and after November 24, 2015, to common shareholders of record at the close of business on October 26, 2015...

Given our ability to consistently generate strong cash flows, today we announced an increase in our dividend of $ 0.50 per share payable on August 1, 2012, to shareholders of record at July 10, 2012.

2015.08.26 Royal Bank of Canada declares dividends Royal Bank of Canada (RY on TSX and NYSE) today announced an increase to its quarterly common share dividend of two cents per share, or three percent, to 79 cents per share, payable on and after November 24, 2015, to common shareholders of record at the close of business on October 26, 2015...

In fact, PepsiCo has raised its annual payout in each of the last 45 years, which makes the company a «Dividend Aristocrat,» a company with at least 25 consecutive years of annual dividend inDividend Aristocrat,» a company with at least 25 consecutive years of annual dividend individend increases.

To earn this title, a company needs to have at least 25 consecutive years of annual dividend increases.

In addition to its reasonable valuation and solid long - term prospects, Caretrust also pays a substantial dividend, yielding over 6 % at recent prices and with a history of regular increases.

Just take a look at industrial conglomerate 3M's dividend history: It hasn't just paid a dividend for 100 consecutive years, but increased it for 60 straight years!

For example, the dividend aristocrats are S&P 500 companies that have paid out dividends at an increasing rate for at least 25 years in a row.

Outside analysts suggest they will increase their dividend at a faster rate over the next two years and possibly pay a one time special dividend.

The company traditionally makes a dividend increase announcement at this time of year, and some believe that some of the billions in repatriated cash could go back to investors in the form of dividends or stock buybacks.

• Stellar dividend resume: Decent yield at 2.9 %; excellent dividend growth rate of 20 % over the past 5 years; upcoming increase of 14 % in December; strong dividend safety, protected by very good cash flow; and 44 - year streak of increasing dividends.

While the current price / peak - earnings multiple is already at an elevated level above 18, what I'll call the «P / E equivalent» multiples on other fundamentals are: 21 on the basis of book values, nearly 23 on the basis of enterprise value / EBITDA (which factors in the increasing share of debt on corporate balance sheets), over 25 on the basis of revenues, and 29 on the basis of dividends (largely because dividend payout ratios remain relatively low even on the basis of normalized earnings).

The company has a 33 - year track record of annual dividend increases, with its most recent having come at the beginning of 2017.